Literature DB >> 29444353

Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study.

John Ashcroft1, Ignacio Duran2, Herbert Hoefeler3, Vito Lorusso4, Diana Lueftner5, Marco Campioni6, Michele Intorcia6, Amit Bahl7.   

Abstract

OBJECTIVES: Patients with multiple myeloma (MM) often experience debilitating skeletal-related events (SREs: pathologic fracture, radiation to bone [RB], surgery to bone [SB] or spinal cord compression [SCC]). This is the first comprehensive, prospective, observational analysis of healthcare resource utilisation (HRU), independently attributed to SREs by investigators, in patients with MM.
METHODS: Eligible patients had lytic bone lesions, life expectancy ≥6 months, Eastern Cooperative Oncology Group performance status ≤2 and ≥1 SRE in the 97 days before enrolment. Data were collected retrospectively for 97 days before enrolment and prospectively for 18-21 months.
RESULTS: Altogether, 153 patients were enrolled from Germany, Italy, Spain and the United Kingdom. Of the 281 observed SREs, 36.7% required inpatient stays (mean duration: 20.6 days per SRE [standard deviation (SD): 22.9]). SB and SCC were the SREs most likely to require stays (72.3% and 50.0% of SREs, respectively); SCC required the longest mean (SD) stay per event (40.5 [40.8] days). Overall, 179 SREs required outpatient visits; this was most likely for RB (74.8%) and least likely for non-vertebral fracture (50.0%).
CONCLUSIONS: All SREs were associated with substantial HRU; therefore, preventing SREs in MM will reduce the economic and resource burden on healthcare systems.
© 2018 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  advanced cancer; bone lesions; healthcare resource utilisation; multiple myeloma; observational research; skeletal-related events

Mesh:

Year:  2018        PMID: 29444353     DOI: 10.1111/ejh.13044

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

1.  Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review.

Authors:  María-Victoria Mateos; Leah Fink; Niranchana Koneswaran; Michele Intorcia; Christina Giannopoulou; Daniela Niepel; Michele Cavo
Journal:  BMC Cancer       Date:  2020-03-03       Impact factor: 4.430

2.  Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness.

Authors:  Manuel Neves; Fernanda Trigo; Bergantim Rui; Cristina João; Paulo Lúcio; Neves Mariana; João Mendes; Hugo Pedrosa; Catarina Geraldes
Journal:  Pharmacoeconomics       Date:  2021-01-31       Impact factor: 4.981

3.  Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma.

Authors:  Hira S Mian; Mark A Fiala; Tanya M Wildes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.